|
2025
|
G/S
|
Online social networking services in the field of cancer patient support Providing a website feat... |
|
2024
|
G/S
|
Promoting public awareness of the need for cancer prevention and the need for healthy diets; busi... |
|
|
G/S
|
Analyzing and compiling business data for natural language and data processing technology, data s... |
|
|
Invention
|
Baff-r targeted chimeric antigen receptor-modified t-cells and uses thereof.
Provided herein are... |
|
|
Invention
|
Clock activators and uses thereof.
Described herein, inter alia, are clock activators and uses t... |
|
|
Invention
|
Pcna inhibitors and uses thereof. inter aliainter alia, are PCNA inhibitors and uses thereof. |
|
|
Invention
|
Bispecific antibodies and uses thereof.
Provided herein are, inter alia, antibody compounds comp... |
|
|
Invention
|
T cells for expression of chimeric antigen receptors and other receptors.
Methods for preparing ... |
|
|
Invention
|
M6a mrna modification in cancer treatment.
Disclosed herein are methods of treating cancer by in... |
|
|
Invention
|
Compositions and methods of making and using ipsc-derived car macrophages. inter aliainter alia, ... |
|
|
Invention
|
Expansion of human group 2 innate lymphoid cells and methods of use thereof.
Provided herein, in... |
|
|
Invention
|
Adeno-associated virus compositions for restoring pah gene function and methods of use thereof.
... |
|
|
Invention
|
Combination therapy for treatment of cancer.
Described herein, inter alia, are combination thera... |
|
|
Invention
|
Chimeric poxvirus compositions and uses thereof.
Provided herein are, inter alia, viral composit... |
|
|
Invention
|
Multi-specific ligand binders.
Provided herein are, inter alia, novel peptide compositions havin... |
|
|
Invention
|
Pcna inhibitors.
Described herein, inter alia, are compositions of PCNA modulators and methods f... |
|
|
Invention
|
Programmable conditional sirnas and uses thereof.
Disclosed herein are programmable, conditional... |
|
|
Invention
|
Compositions and methods of alleviating resistance to chemotherapy.
Disclosed herein are methods... |
|
|
Invention
|
Adeno-associated virus compositions and methods of use thereof. Provided herein, inter alia, are ... |
|
|
Invention
|
System, device and method for production of bioproduct including high density cell respirator (hd... |
|
|
Invention
|
Baff-r antibodies and uses thereof.
Provided herein are BAFF-R antibodies as well as composition... |
|
|
Invention
|
Methods of inducing organ transplantation immune tolerance and associated compositions and method... |
|
|
Invention
|
Multivalent epstein-barr virus-like particles and uses thereof.
Disclosed are vaccine compositio... |
|
|
Invention
|
Membrane-bound il-12 for cellular immunotherapy. This disclosure relates to, inter alia, cells ex... |
|
|
Invention
|
Assays for characterization of extracellular vesicles and methods of using the same. Disclosed he... |
|
|
Invention
|
Cysteine peptide-enabled antibodies.
Provided herein are functionalized monoclonal antibodies (m... |
|
|
Invention
|
Systems and methods related to dosimetry for radioembolization, chemoembolization, and drug eluti... |
|
|
Invention
|
Ctla-4 aptamer conjugates.
Provided herein are, inter alia, nucleic acid compounds useful for ta... |
|
|
Invention
|
Anti-il1rap antibodies and variants thereof. Provided herein are, inter alia, Interleukin-1 recep... |
|
|
Invention
|
Engineered anti-prostate stem cell antigen fusion protein and uses thereof. Disclosed are enginee... |
|
|
Invention
|
Machine learning enabled prognosis of patient mortality.
A method for machine learning enabled m... |
|
|
Invention
|
Mechanically interlocking complexes.
Provided herein are functionalized monoclonal antibodies (m... |
|
2023
|
Invention
|
Stem cells for delivery of oncolytic viruses. inter aliainter alia, are stem cells including an e... |
|
|
G/S
|
Downloadable computer software platforms for database management and data analytics Platform as a... |
|
|
Invention
|
Use of endogenous viral vaccine in chimeric antigen receptor t cell therapy. Provided herein are,... |
|
|
G/S
|
Telemedicine services; Telehealth services; Medical consultations; Medical services |
|
2022
|
Invention
|
Methods of preventing, treating, or reducing the severity of coronavirus disease 2019 (covid-19).... |
|
|
Invention
|
Methods of preventing, treating, or reducing the severity of covid-19 in immunocompromised blood ... |
|
|
Invention
|
Engineering or inducing pdgf and/or pdgfr signaling to enhance nk cell therapy.
Provided herein,... |
|
|
Invention
|
Clostridium butyricum compositions and methods of using the same.
Provided herein, inter alia, a... |
|
|
Invention
|
Anti-cd3 antibodies and uses thereof.
Provided herein are, inter alia, antibodies capable of bin... |
|
|
Invention
|
Compositions and methods for cell-free dna epigenetic gastrointestinal cancer detection and treat... |
|
|
Invention
|
Novel small molecule inhibitors of pus7 and uses thereof.
Disclosed herein are, inter alia, comp... |
|
|
Invention
|
Chimeric antigen receptor t cells targeting gd and oncolytic viruses for cancer therapy and treat... |
|
|
Invention
|
Adeno-associated virus compositions and methods of use thereof.
Provided herein, inter alia, are... |
|
|
Invention
|
Methods for detecting dysfunctional nk cells in leukemia patients.
Provided herein are, inter al... |
|
|
Invention
|
Pcna inhibitors and egfr inhibitors for cancer treatment.
Described herein are, inter alia, meth... |
|
|
Invention
|
Cancer treatment by targeting proteins or interactions of ephrinb-rgs3-kif20a-sept7 axis.
A meth... |
|
|
Invention
|
Lipid nanoparticles and methods of use.
Provided herein are, inter alia, lipid nanoparticles, li... |
|
|
Invention
|
Car t cell therapy and ifn gamma.
Provided herein are, inter alia, compositions comprising chime... |
|
|
Invention
|
Anti-hvem antibodies.
Provided herein are, inter alia, antibodies (e.g. humanized antibodies, mo... |
|
|
Invention
|
Truncated domain iv egfr and uses thereof.
A truncated EGFR (tEGFR) cell surface molecule and it... |
|
|
Invention
|
Anti-domain iv egfr antibodies and uses thereof.
Provided herein are, inter alia, novel antibodi... |
|
|
Invention
|
Natural killer cells engineered to reduce or eliminate cbl-b and uses thereof.
Described herein ... |
|
2021
|
Invention
|
Vaccination of hematopoietic stem cell donors with cytomegalovirus triplex composition.
Disclose... |
|
2020
|
G/S
|
Downloadable webinars in the field of medical conditions and diseases; Downloadable webinars in t... |
|
2011
|
G/S
|
Newsletters in the field of medical care, healthcare, disease and chronic illness information, ca... |
|
|
G/S
|
Providing temporary housing accommodations to patients and families |
|
|
G/S
|
Healthcare services |
|
|
G/S
|
Downloadable electronic newsletters in the field of medical care, healthcare, disease and chronic... |
|
|
G/S
|
Medical and scientific research, namely, conducting clinical trials |
|
|
G/S
|
Entertainment and recreational services, namely, providing physical fitness and yoga instruction |
|
|
G/S
|
Charitable fundraising services |
|
2007
|
G/S
|
Newsletters in the field of medical care, health care, and disease information |
|
2006
|
G/S
|
Charitable fundraising services Medical research services Hospital services |
|
1996
|
G/S
|
telephone information services, namely, providing information regarding diseases |
|
1990
|
G/S
|
providing incentives to people to demonstrate excellence in humanitarian and social endeavors thr... |
|
1984
|
G/S
|
Hospital and Medical Research Services |
